SEPTERNA

Welcome to the Brand page for “SEPTERNA”, which is offered here for Custom manufacture of biochemical systems, custom manufacture of systems for targeting g-protein coupled receptors (gpcrs), gpcr ligands, gpcr transducer proteins, and gpcr interacting proteins; custom manufacturing for others, manufacturing of pharmaceutical preparations for the treatment of neurological disorders, endocrine disorders, metabolic disorders, autoimmune diseases and immunological disorders, cancer, cardiovascular disorders, gastrointestinal disorders, pain, ophthalmic disorders, psychiatric disorders, respiratory disorders, urologic and reproductive disorders, and musculoskeletal disorders;pharmaceutical preparations for modulating g-protein coupled receptors (gpcrs), gpcr ligands, gpcr transducer proteins, and gpcr interacting proteins; pharmaceutical preparations for use in neurology, endocrinology, metabolism, immunology, oncology, cardiovascular medicine, gastroenterology, pain, anesthesiology, dermatology, ophthalmology, psychiatry, pulmonology, urology, reproductive medicine, and orthopedics; pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, and that act on various gpcrs, gpcr ligands, gpcr transducer proteins, and gpcr interacting proteins; chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of neurological disorders, endocrine disorders, metabolic disorders, autoimmune diseases and immunological disorders, cancer, cardiovascular disorders, gastrointestinal disorders, pain, ophthalmic disorders, psychiatric disorders, respiratory disorders, urologic and reproductive disorders, and musculoskeletal disorders; pharmaceutical preparations for targeting gpcrs, gpcr ligands, gpcr transducer proteins, and gpcr interacting proteins; biological preparations for the treatment of neurological disorders, endocrine disorders, metabolic disorders, autoimmune diseases and immunological disorders, cancer, cardiovascular disorders, gastrointestinal disorders, pain, ophthalmic disorders, psychiatric disorders, respiratory disorders, urologic and reproductive disorders, and musculoskeletal disorders;biochemical and chemical reagents for testing and characterizing g protein-coupled receptors (gpcrs), for scientific or medical research use; chemical reagents for use in genetic research;bio-technology and scientific services, research, and production and development services relating to bio-technology and science, g-protein coupled receptors (gpcrs), gpcr ligands, gpcr transducer proteins, and gpcr interacting proteins; pharmaceutical research and development; biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research services, treating therapeutic targets through chemical and biochemical preparations; providing a website featuring information about the treatment and/or diagnosis of neurological disorders, endocrine disorders, metabolic disorders, autoimmune diseases and immunological disorders, cancer, cardiovascular disorders, gastrointestinal disorders, pain, ophthalmic disorders, psychiatric disorders, respiratory disorders, urologic and reproductive disorders, and musculoskeletal disorders;.

Its status is currently believed to be active. Its class is unavailable. “SEPTERNA” is believed to be currently owned by “Septerna, Inc.”